8. Molecular Genetics of Familial Cardiomyopathies

Advances in Genetics

Volumn 35, Issue C, 1997, Pages 285-324

  Coonar, Aman S ^a   McKenna, William J ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; MYOSIN; MYOSIN BINDING PROTEIN C; MYOSIN-BINDING PROTEIN C; TROPOMYOSIN; TROPONIN; TROPONIN T;

CARDIOMYOPATHY; CONGESTIVE CARDIOMYOPATHY; FEMALE; GENETICS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; MALE; MOLECULAR BIOLOGY; MUTATION; PATHOLOGY; RESTRICTIVE CARDIOMYOPATHY; REVIEW;

CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; CARDIOMYOPATHY, RESTRICTIVE; CARRIER PROTEINS; FEMALE; HUMANS; LONG QT SYNDROME; MALE; MOLECULAR BIOLOGY; MUTATION; MYOSINS; TROPOMYOSIN; TROPONIN; TROPONIN T;

EID: 0030628995     PISSN: 00652660     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2660(08)60453-8     Document Type: Article

References (191)

1. Abelmann W.H. Classification and natural history of primary myocardial disease. Cardiovasc. Dis. 27 (1984) 73-94
2. Ahn A.H., and Kunkel L.M. The structural and functional diversity of dystrophin. Nat. Genet. 3 (1993) 283-291
3. Anan R., Greve G., Thierfelder L., Watkins H., McKenna W.J., Solomon S., Vecchio C., Shono H., Nakao S., Tanaka H., et al. Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J. Clin. Invest. 93 (1994) 280-285
4. Anastakis A. Hypertrophic Cardiomyopathy in Greek Families (1995), Hippokration Hospital, Athens, Greece in press
5. Anderson P.A., Greig A., Mark T.M., Malouf N.N., Oakeley A.E., Ungerleider R.M., Allen P.D., and Kay B.K. Molecular basis of human cardiac troponin T isoforms expressed in the developing, adult, and failing heart. Circulat. Res. 76 (1995) 681-686
6. Anderson P.A., Malouf N.N., Oakeley A.E., Pagani E.D., and Allen P.D. Troponin T isoform expression in humans: A comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle. Circulat. Res. 69 (1991) 1226-1233
7. Ando H., Imaizumi T., Urabe Y., Takeshita A., and Nakamura M. Apical segmental dysfunction in hypertrophic cardiomyopathy: Subgroup with unique clinical features. JACC 16 (1990) 1579-1588
8. Aroney C., Bett N., and Radford D. Familial restrictive cardiomyopathy. Aust. N. Zeal. J. Med. 18 (1988) 877-878
9. Bejsovec A., and Anderson P. Myosin heavy-chain mutations that disrupt Caenorhabditis elegans thick filament assembly. Genes Dev 2 (1988) 1307-1317
10. Bejsovec A., and Anderson P. Functions of the myosin ATP and actin binding sites are required for C. elegans thick filament assembly. Cell 60 (1990) 133-140
11. Bennett C.P.B., and Moore G. Prevalence of hypertrophic cardiomyopathy in the Northern region of England. J. Med. Genet. 92 (1987) 243
12. Bennett P.B., Yazawa K., Makita N., and George A.J. Molecular mechanism for an inherited cardiac arrhythmia. Nature 376 (1995) 683-685
13. Berko A.B. X-linked dilated cardiomyopathy. N. Engl. J. Med. 316 (1987) 1186-1191
14. Bjarnason I., Jonsson S., and Hardarson T. Mode of inheritance of hypertrophic cardiomyopathy in Iceland: Echocardiographic study. Br. Heart J. 47 (1982) 122-129
15. Bonne G.E.A. Cardiac myosin binding protein C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat. Genet. 11 (1995) 438-440
16. Branzi A., Romeo G., Specchia S., Lolli C., Binetti G., Devoto M., Bacchi M., and Magnani B. Genetic heterogeneity of hypertrophic cardiomyopathy. Int. J. Cardiol. 7 (1985) 129-138
17. Brigden W. Uncommon myocardial diseases: The non-coronary cardiomyopathies. Lancet 2 (1957) 1179-1184 1243-1249
18. Brisson J.R., Golosinska K., Smillie L.B., and Sykes B.D. Interaction of tropomyosin and troponin T: A proton nuclear magnetic resonance study. Biochemistry 25 (1986) 4548-4555
19. Caforio A.L., Bonifacio E., Stewart J.T., Neglia D., Parodi O., Bottazzo G.F., and McKenna W.J. Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. JACC 15 (1990) 1527-1534
20. Caforio A.L., Bottazzo G.F., McKenna W.J., Counihan P.J., Burke M., Poloniecki J., Davies M.J., and Pepper J.R. Class II major histocompatibility complex antigens on cardiac endothelilium: An early biopsy marker of rejection in the transplanted human heart. Transplant. Proc. 22 (1990) 1830-1833
21. Caforio A.L., Grazzini M., Mann J.M., Keeling P.J., Bottazzo G.F., McKenna W.J., and Schiaffino S. Identification of α and β cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 85 (1992) 1734-1742
22. Caforio A.L., and McKenna W.J. Dilated cardiomyopathy: Chronic viral infection or autoimmune disease? A critical view of the viral and the autoimmune hypotheses. Ind. Heart J. 42 (1990) 399-402
23. Caforio A.L., Stewart J.T., Bonifacio E., Burke M., Davies M.J., McKenna W.J., and Bottazzo G.F. Inappropriate major histocompatibility complex expression on cardiac tissue in dilated cardiomyopathy: Relevance for autoimmunity?. J. Autoimmun 3 (1990) 187-200
24. Canciani B., Nava A., Toso V., Martini B., and Thiene G. A casual spontaneous mutation as possible cause of the familial form of arrhythmogenic right ventricular cardiomyopathy (arrhythmogenic right ventricular dysplasia. Clin. Cardiol. 15 (1992) 217-219
25. Carrier L., Hengstenberg C., Beckmann J.S., Guicheney P., Dufour C., Bercovici J., Dausse E., Berebbi B.I., Wisnewsky C., Pulvenis D., et al. Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11. Nat. Genet. 4 (1993) 311-313
26. Codd M.B. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. Circulation 80 (1989) 564-572
27. Coonar A.S. Increasing evidence for the familial nature of dilated cardiomyopathy. Br. Heart J. Suppl. (1995) 199A
28. Coonar A.S. Large dystrophin gene deletions in idiopathic dilated cardiomyopathy. European Heart J. 17 (1996) 323-1803
29. Corrado D., Thiene G., Nava A., Rossi L., and Pennelli N. Sudden death in young competitive athletes: Clinicopathologic correlations in 22 cases. Am. J. Med. 89 (1990) 588-596
30. Coulondre C., Miller J.H., Farabaugh P.J., and Gilbert W. Molecular basis of base substitution hotspots in Escherichia coli. Nature 274 (1978) 775-780
31. Cuda G., Fananapazir L., Zhu W.S., Sellers J.R., and Epstein N.D. Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy. J. Clin. Invest. 91 (1993) 2861-2865
32. Curran M.E., Splawski I., Timothy K.W., Vincent G.M., Green E.D., and Keating M.T. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80 (1995) 795-803
33. Danser A.H., Schalekamp M.A., Bax W.A., van den Brink A.M., Saxena P.R., Riegger G.A., and Schunkert H. Angiotensin-converting enzyme in the human heart: Effect of the deletion/insertion polymorphism. Circulation 92 (1995) 1387 1138
34. Dausse E., Komajda M., Fetler L., Dubourg O., Dufour C., Carrier L., Wisnewsky C., Bercovici J., Hengstenberg C., al-Mahdawi S., et al. Familial hypertrophic cardiomyopathy: Microsatellite haplotyping and identification of a hot spot for mutations in the betamyosin heavy chain gene. J. Clin. Invest. 92 (1993) 2807-2813
35. Dausse E., and Schwartz K. Genetic heterogeneity of familial hypertrophic cardiomyopathy. Neuromusc. Disord. 3 (1993) 483-486
36. Davies M.J. Arrhythmogenic right ventricular dysplasia: The phenotypic range defined. Br. Heart J. 71 3 (1994) 214
37. Davies M.J., and McKenna W.J. Dilated cardiomyopathy: An introduction to pathology and pathogenesis. Br. Heart J. 72 6 (1995) 524 suppl.
38. Dibb N.J., Brown D.M., Karn J., Moerman D.G., Bolten S.L., and Waterston R.H. Sequence analysis of mutations that affect the synthesis, assembly and enzymatic activity of the unc-54 myosin heavy chain of Caenorhabditis elegans. J. Mol. Biol 183 (1985) 543-551
39. Dibb N.J., Maruyama I.N., Krause M., and Karn J. Sequence analysis of the complete Caenorhabditis elegans myosin heavy chain gene family. J. Mol. Biol. 205 (1989) 603-613
40. Dufour C., Dausse E., Fetler L., Dubourg O., Bouhour J.B., Vosberg H.P., Guicheney P., Komajda M., and Schwartz K. Identification of a mutation near a functional site of the β cardiac myosin heavy chain gene in a family with hypertrophic cardiomyopathy. J. of Mol. Cell. Cardio. 26 9 (1994) 1241-1247
41. Durand J.E. Localisation of a gene responsible for familial dilated cardiomyopathy to chromosome 1q32. Circulation 92 (1995) 3387-3389
42. Emanuel R., Withers R., and Brien O.'K. Dominant and recessive modes of inheritance in idiopathic cardiomyopathy. Lancet 2 (1971) 1065-1067
43. Epstein N.D., Cohn G.M., Cyran F., and Fananapazir L. Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the betαmyosin heavy chain gene: A 908Leu → Val mutation and a 403Arg → Gln mutation. Circulation 86 (1992) 345-352
44. Epstein N.D., Fananapazir L., Lin H.J., Mulvihill J., White R., Lalouel J.M., Lifton R.P., Nienhuis A.W., and Leppert M. Evidence of genetic heterogeneity in five kindreds with familial hypertrophic cardiomyopathy. Circulation 85 (1992) 635-647
45. Fananapazir L., Dalakas M.C., Cyran F., Cohn G., and Epstein N.D. Missense mutations in the betamyosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy. Proc. Natl. Acad. Sci. USA 90 (1993) 3993-3997
46. Fananapazir L., and Epstein N.D. Genotype-phenotype correlations in hypertrophic cardiomyopathy: Insights provided by comparisons of kindreds with distinct and identical betamyosin heavy chain gene mutations. Circulation 89 (1994) 22-32
47. Ferraro M., Scarton G., and Ambrosini M. Cosegregation of hypertrophic cardiomyopathy and a fragile site on chromosome 16 in a large Italian family. J. Med. Genet. 27 (1990) 363-366
48. Fisher A.J., Smith C.A., Thoden J., Smith R., Sutoh K., Holden H.M., and Rayment I. Structural studies of myosin:nucleotide complexes: A revised model for the molecular basis of muscle contraction. Biophys. J. 68 4 (1995) 195-285 suppl
49. Fitzpatrick A.P., Shapiro L.M., Rickards A.F., and Poole W.P. Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy. Br. Heart J. 63 (1990) 114-118
50. Fontaine G., Fontaliran F., Frank R., Chomette G., and Grosgogeat Y. Causes of sudden death in athletes. Arch. Maladies Coeur Vaisseaux 2 (1989) 107-111 [In French]
51. Fontaine G., Guedon M.L., Frank R., Lascault G., Fontaliran F., Tonet J., Himbert C., and Grosgogeat Y. Right ventricular dysplasia. Ann. Cardiol. Angeiol. 41 (1992) 399-410 [In French]
52. Fyrberg E., Fyrberg C.C., Beall C., and Saville D.L. Drosophila melanogaster troponin-T mutations engender three distinct syndromes of myofibrillar abnormalities. J. Mol. Biol. 216 (1990) 657-675
53. Gautel M., Zuffardi O., Freiburg A., and Labeit S. Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: A modulator of cardiac contraction?. EMBO J. 14 (1995) 1952-1960
54. Geisterfer L., Kass S., Tanigawa G., Vosberg H.P., McKenna W., Seidman C.E., and Seidman J.G. A molecular basis for familial hypertrophic cardiomyopathy: A beta cardiac myosin heavy chain gene missense mutation. Cell 62 (1990) 999-1006
55. Gillum R.F. Idiopathic dilated cardiomyopathy. Epidemiology 5 (1994) 383-385
56. Goldblatt J. Autosomal recessive inheritance of idiopathic dilated cardiomyopathy in a Madeira Portuguese kindred. Cell. Genet. 31 (1987) 249-254
57. Goodwin J.F. The frontiers of cardiomyopathy. Br. Heart J. 48 (1982) 1-18
58. Goodwin J.G., Hollman H., and Bishop A.M.B. Clinical aspects of cardiomyopathy. Br. Med. J. 1 (1961) 69-79
59. Graber H.L., Unverferth D.V., Baker P.B., Ryan J.M., Baba N., and Wooley C.F. Evolution of a hereditary cardiac conduction and muscle disorder: A study involving a family with six generations affected. Circulation 74 (1986) 21-35
60. Green P.M., Montandon A.J., Bentley D.R., Ljung R., Nilsson I.M., and Giannelli F. The incidence and distribution of CpG → TpG transitions in the coagulation factor IX gene: A fresh look at CpG mutational hotspots. Nucleic Acids Res. 18 (1990) 3227-3231 [Published erratum appears in Nucleic Acids Res. 1813), 4051]
61. Greve G., Bachinski L., Friedman D.L., Czernuzewicz G., Anan R., Towbin J., Seidman C.E., and Roberts R. Isolation of a de novo mutant myocardial beta MHC protein in a pedigree with hypertrophic cardiomyopathy. Hum. Mol. Genet. 3 (1994) 2073-2075
62. Gunning P., Ponte P., Kedes L., Eddy R., and Shows T. Chromosomal location of the co-expressed human skeletal and cardiac actin genes. Proc. Natl. Acad. Sci. USA 81 (1984) 1813-1817
63. Hallidie S.K., and Olsen E.G. Endocardial fibro-elastosis, mitral incompetence, and coarctation of abdominal aorta. Br. Heart J. 30 (1968) 850-858
64. Harada H., Kimura A., Nishi H., Sasazuki T., and Toshima H. A missense mutation of cardiac β-myosin heavy chain gene linked to familial hypertrophic cardiomyopathy in affected Japanese families. Biochem. Biophys. Res. Commun. 30 2 (1993) 791-798 194
65. Hejtmancik J.F., Brink P.A., Towbin J., Hill R., Brink L., Tapscott T., Trakhtenbroit A., and Roberts R. Localization of gene for familial hypertrophic cardiomyopathy to chromosome 14q1 in a diverse US population. Circulation 83 (1991) 1592-1597
66. Hengstenberg C., Charron P., Isnard R., Beckmann J.S., Fetler L., Desnos M., Hagege A., Bouhour J.B., Souriant G., Dubourg O., et al. Demostration of a fifth locus implicated in familial hypertrophic cardiomyopathies. [French] Arch. Mal. Coeur Vaisseaux 87 12 (1994) 1655-1662
67. Hodgson S., Child A., and Dyson M. Endocardial fibroelastosis: Possible X linked inheritance. J. Med. Genet. 24 (1987) 210-214
68. Ishii Y., and Lehrer S.S. Two-site attachment of troponin to pyrene-labeled tropomyosin. J. Biol. Chem. 266 (1991) 6894-6903
69. Jarcho J.A., McKenna W., Pare J.A., Solomon S.D., Holcombe R.F., Dickie S., Levi T., Donis K.H., Seidman J.G., and Seidman C.E. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. N. Engl. J. Med. 321 (1989) 1372-1378
70. Johnson R.A., and Palacios I. Dilated cardiomyopathies of the adult. N. Engl. J. Med. 307 (1982) 1051-1058
71. Kandolf R., Klingel K., Zell R., Canu A., Fortmuller U., Hohenadl C., Albrecht M., Reimann B.Y., Franz W.M., Heim A., et al. Molecular mechanisms in the pathogenesis of enteroviral heart disease: Acute and persistent infections. Clin. Immunol. Immunopathol. 68 (1993) 153-158
72. Kass S., MacRae C., Graber H.L., Sparks E.A., McNamara D., Boudoulas H., Basson C.T., Baker P., Cody R.J., Fishman M.C., et al. A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1-1q1. Nat. Genet. 7 (1994) 546-551
73. Keating M., Atkinson D., Dunn C., Timothy K., Vincent G.M., and Leppert M. Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science 252 (1991) 704-706
74. Keating M., Dunn C., Atkinson D., Timothy K., Vincent G.M., and Leppert M. Consistent linkage of the long-QT syndrome to the Harvey ras-1 locus on chromosome 11. Am. J. Hum. Genet. 49 (1991) 1335-1339
75. Keeling P.J. Familial dilated cardiomyopathy in the UK. Br. Heart J. 73 (1995) 417-421
76. Keeling P.J., Jeffery S., Caforio A.L., Taylor R., Bottazzo G.F., Davies M.J., and McKenna W.J. Similar prevalence of enteroviral genome within the myocardium from patients with idiopathic dilated cardiomyopathy and controls by the polymerase chain reaction. Br. Heart J. 68 (1992) 554-559
77. Kenny A., and Shapiro L.M. Sudden cardiac death in athletes. Br. Med. Bull. 48 (1992) 534-545
78. Keren A., and Popp R.L. Assignment of patients into the classification of cardiomyopathies. Circulation 86 (1992) 1622-1633
79. Kishimoto C., Kaburagi T., Takayama S., Yokoyama S., Hanyu I., Takatsu Y., and Tomimoto K. Two forms of hypertrophic cardiomyopathy distinguished by inheritance of HLA haplotypes and left ventricular outflow tract obstruction. Am. Heart J. 105 6 (1983) 988
80. Kodama M., Hanawa H., Saeki M., Hosono H., Inomata T., Suzuki K., and Shibata A. Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circul. Res. 75 (1994) 278-284
81. Koike S., Kawa S., Yabu K., Endo R., Sasaki Y., Furuta S., and Ota M. Familial dilated cardiomyopathy and human leucocyte antigen: A report of two family cases. Jap. Heart J. 28 (1987) 941-945
82. Krajinovic M., Pinamonti B., Sinagra G., Vatta M., Severini G.M., Milasin J., Falaschi A., Camerini F., Giacca M., and Mestroni L. Linkage of familial dilated cardiomyopathy to chromosome 9. Am. J. Hum. Genet. 57 (1995) 846-852 and group at H.M.D.S.
83. Labeit S., Gautel M., Lakey A., and Trinick J. Towards a molecular understanding of titin. EMBO J. 11 (1992) 1711-1716
84. Lankford E.B., Epstein N.D., Fananapazir L., and Sweeney H.L. Abnormal contractile properties of muscle fibers expressing betamyosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J. Clin. Invest. 95 (1995) 1409-1414
85. Laurent M., Descaves C., Biron Y., Deplace C., Almange C., and Daubert J.C. Familial form of arrhythmogenic right ventricular dysplasia. Am. Heart J. 113 (1987) 827-829
86. Lechin M., Quinones M.A., Omran A., Hill R., Yu Q.T., Rakowski H., Wigle D., Liew C.C., Sole M., Roberts R., and Marian A. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 92 (1995) 1808-1812
87. Lewis J.F., and Maron B.J. Elderly patients with hypertrophic cardiomyopathy: A subset with distinctive left ventricular morphology and progressive clinical course late in life. JACC 13 (1989) 36-45
88. Lewis J.F., and Maron B.J. Clinical and morphologic expression of hypertrophic cardiomyopathy in patients ≥65 years of age. Am. J. Cardiol. 73 (1994) 1105-1111
89. Lichter P., Umeda P.K., Levin J.E., and Vosberg H.P. Partial characterization of the human beta-myosin heavy-chain gene which is expressed in heart and skeletal muscle. Eur. J. Biochem. 160 (1986) 419-426
90. Lindpaintner K., Pfeffer M.A., Kreutz R., Stampfer M.J., Grodstein F., LaMotte F., Buring J., and Hennekens C.H. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N. Engl. J. Med. 332 (1995) 706-711
91. Linz W., Schaper J., Wiemer G., Albus U., and Scholkens B.A. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: A one year study in rats. Br. J. Pharmacol. 107 (1992) 970-975
92. Litt M., and Lutt J. Am. J. Hum. Genet. 44 (1989) 397
93. Liu S.K., Maron B.J., and Tilley L.P. Feline hypertrophic cardiomyopathy: Gross anatomic and quantitative histologic features. Am. J. Pathol. 102 (1981) 388-395
94. Liu S.K., Roberts W.C., and Maron B.J. Comparison of morphologic findings in spontaneously occurring hypertrophic cardiomyopathy in humans, cats and dogs. Am. J. Cardiol. 72 (1993) 944-951
95. Lompre A.M., Nadal G.B., and Mahdavi V. Expression of the cardiac ventricular alpha and beta-myosin heavy chain genes is developmentally and hormonally regulated. J. Biol. Chem. 259 (1984) 6437-6446
96. Machida M. Genetic heterogeneity of hypertrophic cardiomyopathy in Japanese. Hokkaido Igaku Zasshi Hokkaido J. Med. Sci. 69 (1994) 1024-1034 [In Japanese]
97. MacRae C.A., Watkins H.C., Jarcho J.A., Thierfelder L., McKenna W.J., Seidman J.G., and Seidman C.E. An evaluation of ribonuclease protection assays for the detection of betα cardiac myosin heavy chain gene mutations. Circulation 89 (1994) 33-35
98. Macrae C.E. Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J. Clin. Invest. 96 (1995) 1216-1220
99. Malouf N.N., McMahon D., Oakeley A.E., and Anderson P.A. A cardiac troponin T epitope conserved across phyla. J. Biol. Chem. 267 (1992) 9269-9274
100. Manolio T.A., Baughman K.L., Rodeheffer R., Pearson T.A., Bristow J.D., Michels V.V., Abelmann W.H., and Harlan W.R. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop. Cardiol. 69 (1992) 1458-1466
101. Marcus F.I., and Fontaine G. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: A review. Pac. Clin. Electrophysiol. 18 (1995) 1298-12314
102. Marian A.J., Yu Q.T., Mann D.L., Graham F.L., and Roberts R. Expression of a mutation causing hypertrophic cardiomyopathy disrupts sarcomere assembly in adult feline cardiac myocytes. Circul. Res. 77 (1995) 98-106
103. Marian A.J., Yu Q.T., Mares A.J., Hill R., Roberts R., and Perryman M.B. Detection of a new mutation in the beta-myosin heavy chain gene in an individual with hypertrophic cardiomyopathy. J. Clin. Invest. 90 (1992) 2156-2165
104. Maron B. Hypertrophic cardiomyopathy in infants: Clinical features and natural history. Circulation 65 (1982) 7
105. Maron B.J., Epstein S.E., and Roberts W.C. Hypertrophic cardiomyopathy: A common cause of sudden death in the young competitive athlete. Eur. Heart J. Nov. 4 Suppl F (1983) 135-144
106. Maron B.J., Gardin J.M., Flack J.M., Gidding S.S., Kurosaki T.T., and Bild D.E. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circ 92 (1995) 785-789
107. Maron B.J., Spirito P., Wesley Y., and Arce J. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N. Engl. J. Med. 315 (1986) 610-614
108. Matsumori A., Kawai C., Wakabayashi A., Terasaki P.I., Park M.S., Sakurami T., and Ueno Y. HLA-DRW4 antigen linkage in patients with hypertrophic obstructive cardiomyopathy. Am. Heart J. 101 1 (1981) 14
109. Matsuoka R., Chambers A., Kimura M., Kanda N., Bruns G., Yoshida M., and Takao A. Molecular cloning and chromosomal localization of a gene coding for human cardiac myosin heavy-chain. Am. J. Med. Genet. 29 (1988) 369-376
110. Matsuoka R., Yoshida M.C., Kanda N., Kimura M., Ozasa H., and Takao A. Human cardiac myosin heavy chain gene mapped within chromosome region 14q11.2 → q13. Am. J. Med. Genet. 32 (1989) 279-284
111. McKenna W., Deanfield J., Faruqui A., England D., Oakley C., and Goodwin J. Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic and hemodynamic features. Am. J. Cardiol. 47 (1981) 532-538
112. McKenna W.J., Thiene G., Nava A., Fontaliran F., Blomstrom L.C., Fontaine G., and Camerini F. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy: Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br. Heart J. 71 (1994) 215-218
113. McKusick V. Mendelian inheritance in Man. (1996). http://www3.ncbi.nlm.nih.gov/omim/ Internet access at http://www3.ncbi.nlm.nih.gov/omim/
114. Mestroni L., Miani D., Di L.A., Silvestri F., Bussani R., Filippi G., and Camerini F. Clinical and pathologic study of familial dilated cardiomyopathy. Am. J. Cardiol. 65 (1990) 1449-1453
115. Michels V.V., Moll P.P., Miller F.A., Tajik A.J., Chu J.S., Driscoll D.J., Burnett J.C., Rodeheffer R.J., Chesebro J.H., and Tazelaar H.D. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N. Engl. J. Med. 326 (1992) 77-82
116. Michels V.V., Pastores G.M., Moll P.P., Driscoll D.J., Miller F.A., Burnett J.C., Rodeheffer R.J., Tajik J.A., Beggs A.H., Kunkel L.M., et al. Dystrophin analysis in idiopathic dilated cardiomyopathy. J. Med. Genet. 30 (1993) 955-957
117. Mitchell E.J., Karn J., Brown D.M., Newman A., Jakes R., and Kendrick J.J. Regulatory and essential light-chain-binding sites in myosin heavy chain subfragment-1 mapped by site-directed mutagenesis. J. Mol. Biol. 208 (1989) 199-205
118. Mogami K., Fujita S.C., and Hotta Y. Identification of Drosophila indirect flight muscle myofibrillar proteins by means of two-dimensional electrophoresis. J. Biochem. 91 (1982) 643-650
119. Mogami K., and Hotta Y. Isolation of Drosophila flightless mutants which affect myofibrillar proteins of indirect flight muscle. Mol. Gen. Genet. 183 (1981) 409-417
120. Moolman J.C., Brink P.A., and Corfield V.A. Identification of a new missense mutation at Arg403, a CpG mutation hotspot, in exon 13 of the beta-myosin heavy chain gene in hypertrophic cardiomyopathy. Hum. Mol. Genet. 2 10 (1993) 1731
121. Muntoni F., Cau M., Ganau A., Congiu R., Arvedi G., Mateddu A., Marrosu M.G., Cianchetti C., Realdi G., Cao A., et al. Brief report: Deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N. Engl. J. Med. 329 (1993) 921-925
122. Muntoni F., Wilson L., Marrosu G., Marrosu M.G., Cianchetti C., Mestroni L., Ganau A., Dubowitz V., and Sewry C. A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart. J. Clin. Invest. 96 (1995) 693-699
123. Nava A., Scognamiglio R., Thiene G., Canciani B., Daliento L., Buja G., Stritoni P., Fasoli G., and Dalla V.S. A polymorphic form of familial arrhythmogenic right ventricular dysplasia. Am. J. Cardiol. 59 (1987) 1405-1409
124. Nishi H., Kimura A., Harada H., Adachi K., Koga Y., Sasazuki T., and Toshima H. Possible gene dose effect of a mutant cardiac beta myosin heavy chain gene on the clinical expression of familial hypertrophic cardiomyopathy. Biochem. Biophys. Res. Commun. 200 (1994) 549-556
125. Olson T.M., and Keating M.T. Mapping a cardiomyopathy locus to chromosome 3p22-p25. J. Clin. Invest. 97 (1996) 528-532
126. Pan B.S., Gordon A.M., and Potter J.D. Deletion of the first 45 NH2-terminal residues of rabbit skeletal troponin T strengthens binding of troponin to immobilized tropomyosin. J. Biol. Chem. 266 (1991) 12432-12438
127. Parker T.G. Molecular biology of cardiac growth and hypertrophy. Herz 18 (1993) 245-255
128. Parker T.G., and Schneider M.D. Growth factors, proto-oncogenes, and plasticity of the cardiac phenotype. Annu. Rev. Physiol. 53 (1991) 179-200
129. Pearlstone J.R., Carpenter M.R., and Smillie L.B. Amino acid sequence of rabbit cardiac troponin T. J. Biol. Chem. 261 (1986) 16795-16810
130. Perryman M.B., Yu Q.T., Marian A.J., Mares A.J., Czernuszewicz G., Ifegwu J., Hill R., and Roberts R. Expression of a missense mutation in the messenger RNA for beta myosin heavy chain in myocardial tissue in hypertrophic cardiomyopathy. J. Clin. Invest. 90 (1992) 271-277
131. Pfeffer M.A. ACE inhibition in acute myocardial infarction. N. Engl. J. Med. 332 (1995) 118-120
132. Pfeffer M.A., Braunwald E., Moye L.A., Basta L., Brown E.J., Cuddy T.E., Davis B.R., Geltman E.M., Goldman S., Flaker G.C., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival and ventricular enlargement trial. The SAVE Investigators. N. Engl. J. Med. 327 (1992) 669-677
133. Protonotarios N., Tsatsopoulou A., Patsourakos P., Alexopoulos D., Gezerlis P., Simitsis S., and Scampardonis G. Cardiac abnormalities in familial palmoplantar keratosis. Br. Heart J. 56 (1986) 321-326
134. Rampazzo A., Nava A., Danieli G.A., Buja G., Daliento L., Fasoli G., Scognamiglio R., Corrado D., and Thiene G. The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24. Hum. Mol. Genet. 3 (1994) 959-962
135. Rayment I., and Holden H.M. The three-dimensional structure of a molecular motor. Trends Biochem. Sci. 19 (1994) 129-134
136. Rayment I., Holden H.M., Sellers J.R., Fananapazir L., and Epstein N.D. Structural interpretation of the mutations in the β-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. Proc. Natl. Acad. Sci. USA 92 (1995) 3864-3868
137. Rayment I., Holden H.M., Whittaker M., Yohn C.B., Lorenz M., Holmes K.C., and Milligan R.A. Structure of the actin-myosin complex and its implications for muscle contraction. Science 261 (1993) 58-65
138. Rayment I., Rypniewski W.R., Schmidt B.K., Smith R., Tomchick D.R., Benning M.M., Winkelmann D.A., Wesenberg G., and Holden H.M. Three-dimensional structure of myosin subfragment-1: A molecular motor. Science 261 (1993) 50-58
139. Reid J.M., Houston A.B., and Lundmark E. Hypertrophic cardiomyopathy in identical twins. Br. Heart J. 62 (1989) 384-388
140. Rideout W., Coetzee G.A., Olumi A.F., and Jones P.A. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 249 (1990) 1288-1290
141. Rigat B., Hubert C., Alhenc G.F., Cambien F., Corvol P., and Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86 (1990) 1343-1346
142. Rigat B., Hubert C., Corvol P., and Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1. Nucleic Acids Res. 20 6 (1992) 1433
143. Roberts W.C. Defining idiopathic dilated cardiomyopathy: A courtroom discussion. Am. J. Cardiol. 63 (1989) 893-896
144. Roberts W.C., Siegel R.J., and McManus B.M. Idiopathic dilated cardiomyopathy: Analysis of 152 necropsy patients. Am. J. Cardiol. 60 (1987) 1340-1355
145. Rosenweig A., Watkins H., Hwang D.S., Miri M., McKenna W., Traill T.A., Seidman J.G., and Seidman C.E. Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes. N. Engl. J. Med. 325 (1991) 1753-1760
146. Ross R.S., Bulkley B.H., Hutchins G.M., Harshey J.S., Jones R.A., Kraus H., Liebman J., Thorne C.M., Weinberg S.B., Weech A.A., and Weech A.J. Idiopathic familial myocardiopathy in three generations: A clinical and pathologic study. Am. Heart J. 96 (1978) 170-178
147. Sadoshima J., and Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circul. Res. 73 (1993) 413-423
148. Saez L.J., Gianola K.M., McNally E.M., Feghali R., Eddy R., Shows T.B., and Leinwand L.A. Human cardiac myosin heavy chain genes and their linkage in the genome. Nucleic Acids Res. 15 (1987) 5443-5459
149. Sakamoto T., Tei C., Murayama M., Ichiyasu H., and Hada Y. Giant T wave insertion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle: Echocardiographic and ultrasono-cardiotomographic study. Jap. Heart J. 17 (1976) 611-629
150. Sanguinetti M.C., Jiang C., Curran M.E., and Keating M.T. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 81 (1995) 299-307
151. Schleef M., Werner K., Satzger U., Kaupmann K., and Jockusch H. Chromosomal localization and genomic cloning of the mouse alpha-tropomyosin gene Tpm-1. Genomics 17 (1993) 519-521
152. Schott J.J., Charpentier F., Peltier S., Foley P., Drouin E., Bouhour J.B., Donnelly P., Vergnaud G., Bachner L., Moisan J.P., et al. Mapping of a gene for long QT syndrome to chromosome 4q25-27. Am. J. Hum. Genet. 57 (1995) 1114-1122
153. Schroder R.R., Manstein D.J., Jahn W., Holden H., Rayment I., Holmes K.C., and Spudich J.A. Three-dimensional atomic model of F-actin decorated with Dictyostelium myosin S1. Nature 364 (1993) 171-174
154. Schunkert H., Jackson B., Tang S.S., Schoen F.J., Smits J.F., Apstein C.S., and Lorell B.H. Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts. Circulation 87 (1993) 1328-1339
155. Severini G.E.A. A new locus for arrhythmogenic right ventricular dysplasia on the long arm of chromosome 14. Genomics 31 (1996) 193-200
156. Siewertsen M.A., Vosberg H.P., and Cox D.W. A polymorphism of the MYH7 gene. Nucleic Acids Res. 18 20 (1990) 6173
157. Sinha A.M., Umeda P.K., Kavinsky C.J., Rajamanickam C., Hsu H.J., Jakovcic S., and Rabinowitz M. Molecular cloning of mRNA sequences for cardiac alpha and beta form myosin heavy chains: Expression in ventricles of normal, hypothyroid, and thyrotoxic rabbits. Proc. Natl. Acad. Sci. USA 79 (1982) 5847-5851
158. Sole M.J., and Liu P. Viral myocarditis: A paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy. JACC. 22 (1993) 99A-105A (4 suppl A)
159. Solomon S.D., Geisterfer L.A., Vosberg H.P., Hiller G., Jarcho J.A., Morton C.C., McBride W.O., Mitchell A.L., Bale A.E., McKenna W.J., et al. A locus for familial hypertrophic cardiomyopathy is closely linked to the cardiac myosin heavy chain genes, CRI-L436, and CRI-L329 on chromosome 14 at q11-q12. Am. J. Hum. Genet. 47 (1990) 389-394
160. Solomon S.D., Jarcho J.A., McKenna W., Geisterfer L.A., Germain R., Salerni R., Seidman J.G., and Seidman C.E. Familial hypertrophic cardiomyopathy is a genetically heterogeneous disease. J. Clin. Invest. 86 (1990) 993-999
161. Solomon S.D., Wolff S., Watkins H., Ridker P.M., Come P., McKenna W.J., Seidman C.E., and Lee R.T. Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain gene. JACC 22 (1993) 498-505
162. Spirito P., Chiarella F., Carratino L., Berisso M.Z., Bellotti P., and Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N. Engl. J. Med. 320 (1989) 749-755
163. Spirito P., and Maron B.J. Relation between extent of left ventricular hypertrophy and age in hypertrophic cardiomyopathy. JACC 13 (1989) 820-823
164. Sweeney H.L., Straceski A.J., Leinwand L.A., Tikunov B.A., and Faust L. Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. J. Biol. Chem. 269 (1994) 1603-1605
165. Tanigawa G., Jarcho J.A., Kass S., Solomon S.D., Vosberg H.P., Seidman J.G., and Seidman C.E. A molecular basis for familial hypertrophic cardiomyopathy: An alpha/beta cardiac myosin heavy chain hybrid gene. Cell 62 (1990) 991-998
166. Thierfelder L., MacRae C., Watkins H., Tomfohrde J., Williams M., McKenna W., Bohm K., Noeske G., Schlepper M., Bowcock A., et al. A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2. Proc. Natl. Acad. Sci. USA 90 (1993) 6270-6274
167. Thierfelder L., Watkins H., MacRae C., Lamas R., McKenna W., Vosberg H.P., Seidman J.G., and Seidman C.E. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere. Cell 77 (1994) 701-712
168. Towbin J.A., Hejtmancik J.F., Brink P., Gelb B., Zhu X.M., Chamberlain J.S., McCabe E.R., and Swift M. X-linked dilated cardiomyopathy: Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 87 (1993) 1854-1865
169. Trinick J. Titin and nebulin: Protein rulers in muscle?. Trends Biochem. Sci 19 (1994) 405-409
170. Wang Q., Shen J., Splawski I., Atkinson D., Li Z., Robinson J.L., Moss A.J., Towbin J.A., and Keating M.T. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 80 (1995) 805-811
171. Wang Q.C., Splawski I., et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat. Genet. 12 (1996) 17-23
172. Watkins H. Multiple disease genes cause hypertrophic cardiomyopathy. Br. Heart J (1995)
173. Watkins H., MacRae C., Thierfelder L., Chou Y.H., Frenneaux M., McKenna W., Seidman J.G., and Seidman C.E. A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3. Nat. Genet. 3 (1993) 333-337
174. Watkins H., McKenna W.J., Thierfelder L., Suk H.J., Anan R., Donoghue O.'A., Spirito P., Matsumori A., Moravec C.S., Seidman J.G., et al. Mutations in the genes for cardiac tro-ponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N. Engl. J. Med. 332 (1995) 1058-1064
175. Watkins H., Rosenzweig A., Hwang D.S., Levi T., McKenna W., Seidman C.E., and Seidman J.G. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N. Engl. J. Med. 326 (1992) 1108-1114
176. Watkins H., Thierfelder L., Anan R., Jarcho J., Matsumori A., McKenna W., Seidman J.G., and Seidman C.E. Independent origin of identical beta cardiac myosin heavy-chain mutations in hypertrophic cardiomyopathy. Am. J. Hum. Genet. 53 (1993) 1180-1185
177. Watkins H., Thierfelder L., Hwang D.S., McKenna W., Seidman J.G., and Seidman C.E. Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations. J. Clin. Invest. 90 (1992) 1666-1671
178. Watkins H. Multiple disease genes cause hypertrophic cardiomyopathy. Br. Heart J. 72 6 (1994) 54-59 suppl
179. Watkins H.E.A. A mutated cardiac myosin binding proten-C gene on chromosome 11 causes familial hypertrophic cardiomyopathy. Nat. Genet. 11 (1995) 435-437
180. Weber J.L. Human DNA polymorphisms and methods of analysis. Curr. Opin. Biotechnol. 1 (1990) 166-171
181. Weber J.L. Informativeness of human (dC-dA)n.(dG-dT)n polymorphisms. Genomics 7 (1990) 524-530
182. Weber J.L., and May P.E. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am. J. Hum. Genet. 44 (1989) 388-396
183. White S.P., Cohen C., and Phillips G.J. Structure of co-crystals of tropomyosin and troponin. Nature 325 (1987) 826-828
184. WHO/ISFC. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br. Heart J. 44 (1980) 672-673
185. WHO/ISFC. Report of 1995 WHO/ISFC Task Force on the definition and classification of cardiomyopathies. Circulation 93 5 (1996) 841-842
186. Yamaguchi H., Ishimura T., Nishiyama S., Nagasaki F., Nakanishi S., Takatsu F., Nishijo T., Umeda T., and Machii K. Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): Ventriculographic and echocardiographic features in 30 patients. Am. J. Cardiol. 44 (1979) 401-412
187. Yoshida K., Ikeda S., Nakamura A., Kagoshima M., Takeda S., Shoji S., and Yanagisawa N. Molecular analysis of the Duchenne muscular dystrophy gene in patients with Becker muscular dystrophy presenting with dilated cardiomyopathy. Muscle Nerve 16 (1993) 1161-1166
188. Youssoufian H., Antonarakis S.E., Bell W., Griffin A.M., and Kazazian H.J. Nonsense and missense mutations in hemophilia A: Estimate of the relative mutation rate at CG dinucleotides. Am. J. Hum. Genet. 42 (1988) 718-725
189. Yu Q.T., Ifegwu J., Marian A.J., Mares A.J., Hill R., Perryman M.B., Bachinski L.L., Roberts R., and Marian A.J. Hypertrophic cardiomyopathy mutation is expressed in messenger RNA of skeletal as well as cardiac muscle Circulation 87 (1993) 406-412 [Published errata appear in Circulation 87(5):1775 and 87(6):2070]
190. Zachara E., Caforio A.L., Carboni G.P., Pellegrini A., Pompili A., Del P.G., Sciarra A., Bosman C., Boldrini R., Prati P.L., et al. Familial aggregation of idiopathic dilated cardiomyopathy: Clinical features and pedigree analysis in 14 families. Br. Heart J. 69 (1993) 129-135
191. Zot A.S., and Potter J.D. Structural aspects of troponin-tropomyosin regulation of skeletal muscle contraction. Annu. Rev. Biophys. Biophys. Chem. 16 (1987) 535-559